Order Article Reprints

Bekeschus S, Freund E, Spadola C, Privat-Maldonado A, Hackbarth C, Bogaerts A, Schmidt A, Wende K, Weltmann K-D, von Woedtke T, et al. Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Cancers. 2019; 11(9):1237. https://doi.org/10.3390/cancers11091237

Bekeschus, Sander, Eric Freund, Chiara Spadola, Angela Privat-Maldonado, Christine Hackbarth, Annemie Bogaerts, Anke Schmidt, Kristian Wende, Klaus-Dieter Weltmann, Thomas von Woedtke, and et al. 2019. "Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis" Cancers 11, no. 9: 1237. https://doi.org/10.3390/cancers11091237

Bekeschus, S., Freund, E., Spadola, C., Privat-Maldonado, A., Hackbarth, C., Bogaerts, A., Schmidt, A., Wende, K., Weltmann, K.-D., von Woedtke, T., Heidecke, C.-D., Partecke, L.-I., & Käding, A. (2019). Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis. Cancers, 11(9), 1237. https://doi.org/10.3390/cancers11091237